U2AF1 and myelodysplastic syndrome: The significance of U2AF1 mutations in MDS cohorts without del(20q) is variable, in a few cohorts they have no prognostic impact or are confined to low‐risk patients,7, 8 while in others U2AF1 mutations show a significant correlation with a worse OS.4, 9, 10